TLR3 signaling does not affect organ-specific immune responses to factor IX in AAV gene therapy

Blood

Volumn 112, Issue 3, 2008, Pages 910-911

  Cao, Ou ^b   Herzog, Roland W ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 9; PARVOVIRUS VECTOR; TOLL LIKE RECEPTOR 3; TLR3 PROTEIN, MOUSE;

ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; GENE THERAPY; GENE TRANSFER; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LETTER; NONHUMAN; PRIORITY JOURNAL; ADENOVIRUS; ANIMAL; GENE VECTOR; GENETICS; HUMAN; IMMUNOLOGY; METHODOLOGY; MOUSE; SIGNAL TRANSDUCTION;

ADENOVIRIDAE; ANIMALS; ANTIBODY FORMATION; FACTOR IX; GENE THERAPY; GENETIC VECTORS; HUMANS; MICE; ORGAN SPECIFICITY; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 3;

EID: 50949113924     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-02-137992     Document Type: Letter

References (10)

1. Nathwani AC, Davidoff A, Hanawa H, Zhou JF, Vanin EF, Nienhuis AW. Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA. Blood. 2001;97:1258-1265.
2. + T cells in tolerance to the transgene product following hepatic in vivo gene transfer. Blood. 2007;110:1132-1140.
3. Dobrzynski E, Herzog RW. Tolerance induction by viral in vivo gene transfer. Clin Med Res. 2005;3:234-240.
4. Wang L, Dobrzynski E, Schlachterman A, Gao O, Herzog RW. Systemic protein delivery by muscle-gene transfer is limited by a local immune response. Blood. 2005;105:4226-4234.
5. Wang L, Gao O, Swalm B, Dobrzynski E, Mingozzi F, Herzog RW. Major role of local immune responses in antibody formation to factor IX in AAV gene transfer. Gene Then 2005;12:1453-1464.
6. Lang KS, Georgiev P, Recher M, et al. Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling. J Clin Invest. 2006; 116:2456-2463.
7. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptors. Nature. 2001;413:732-738.
8. Schreiner B, Voss J, Wischhusen J, et al. Expression of toll-like receptors by human muscle cells in vitro and in vivo: TLR3 is highly expressed in inflammatory and HIV myopathies, mediates IL-8 release and up-regulation of NKG2D-ligands. FASEB J. 2006;20:118-120.
9. Manno CS, Chew AJ, Hutchison S, et al. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood. 2003;101:2963-2972.
10. Manno CS, Pierce GF Arruda VR, et al. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med. 2006;12:342-347.